Dongkuk Pharmaceutical signed a license and supply contract for ‘Euresco Tablet’, an improved new drug combination drug for the treatment of benign prostatic hyperplasia. Dongkuk Pharmaceutical announced on the 1st that it signed a license and supply contract for Euresco Tablet worth a total of 39 billion won for the next 10 years in 13 Central and South American countries, including Mexico, Colombia, and Ecuador, with Spanish global pharmaceutical company FAES FARMA. This contract includes a deposit of up to 2...